Abstract
Results baseline LVEF was similar (p = 0.2) between ACE e BB groups, 61.9 ± 5% and 58,3 ± 7% respectively. DUAL group had a lower mean LVEF of 54 ± 11%. At follow up, LVEF was unchanged in ACE group ( from 61.9 to 61.2%), and improved in BB group, from 58 to 63% (p = 0,04). In DUAL group LVEF improved in a similar extent from 54 to 59% (p 0,01). Myocardial T2 STIR edema, significantly decreased at f.u. in all groups. All the remaining CMR parameters had non-significant modification from baseline to f.u.; LGE mass showed borderline significance toward reduction (p = 0.066).
Highlights
No therapy is recommended for hemodynamically stable acute myocarditis patients
We analyzed CMR data form 44 patients hospitalized from our E.D. with acute myocarditis
left ventricular ejection fraction (LVEF) was unchanged in ACE group, and improved in BB group, from 58 to 63% (p = 0,04)
Summary
No therapy is recommended for hemodynamically stable acute myocarditis patients. Lorenzo Monti1,2*, Claudio Moro3, Lucia Occhi2, Veronica Lisignoli2,1, Giuseppe Iacuitti3, Daniela Pini2, Barbara Nardi1,2, Maddalena Lettino2, Luca Balzarini1 From 17th Annual SCMR Scientific Sessions New Orleans, LA, USA. Background No therapy is recommended for hemodynamically stable acute myocarditis patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have